
Supplementary Figure 1 D B A C 3 (51~75%) 2 (26~50%) 1 (1~25%) 4 (76~100%) E F G H 3 (strong) 2 (moderate) 0 (negative) 1 (weak)
Supplementary Figure 2 A SW480 HT29 C D ANGPTL2/GAPDH ANGPTL2/GAPDH ANGPTL2/GAPDH E B F SW480 HT29 ANGPTL2 (OD) ANGPTL2 (OD) ANGPTL2 (OD)
Supplementary Figure 3 A B Stage I CRC patients with CEA <5 CRC patients with CEA <5 100 100 80 80 60 60 Sensitivity Sensitivity 40 40 20 20 AUC = 0.804 AUC = 0.859 0 0 0 20 40 60 80 100 0 20 40 60 80 100 100-Specificity 100-Specificity